Journal of the National Comprehensive Cancer Network : JNCCN · 2011
NCCN Clinical Practice Guidelines Occult primary.
СтатьяКлинические рекомендацииНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ettinger David S, Agulnik Mark, Cates Justin M M, Cristea Mihaela, Denlinger Crystal S, Eaton Keith D, Fidias Panagiotis M, Gierada David, Gockerman Jon P, Handorf Charles R, Iyer Renuka, Lenzi Renato, Phay John, Rashid Asif, Saltz Leonard, Shulman Lawrence N, Smerage Jeffrey B, Varadhachary Gauri R, Zager Jonathan S, Zhen Weining Ken, National Comprehensive Cancer Network
Аннотация
Occult primary tumors, or cancers of unknown primary (CUPs), are defined as histologically proven metastatic malignant tumors whose primary site cannot be identified during pretreatment evaluation. They have a wide variety of clinical presentations and a poor prognosis in most patients. Patients with occult primary tumors often present with general complaints, such as anorexia and weight loss. Clinical absence of primary tumor, early dissemination, aggressiveness, and unpredictability of metastatic pattern are characteristic of these tumors. Life expectancy is very short, with a median survival of 6 to 9 months. In most patients, occult primary tumors are refractory to systemic treatments, and chemotherapy is only palliative and does not significantly improve long-term survival. However, certain clinical presentations of these tumors are associated with a better prognosis. Special pathologic studies can identify subsets of patients with tumor types that are more responsive to chemotherapy. Treatment options should be individualized for this selected group of patients to achieve improved response and survival rates.